.png)
Remote Photoplethysmography-Based HbA1c Estimation for Community Screening of Type 2 Diabetes Mellitus: Screening Tool or Diagnostic Alternative?
Abstract
Type 2 diabetes mellitus (T2DM) remains a major global health burden, with a high proportion of undiagnosed cases, particularly in community settings with limited access to laboratory testing. Remote photoplethysmography (rPPG) has emerged as a non-invasive, camera-based technology with potential for scalable screening. This study aimed to evaluate the agreement, diagnostic performance, and clinical role of rPPG-derived HbA1c as a screening tool or diagnostic alternative for T2DM. A cross-sectional diagnostic validation study was conducted among adults in a community setting in Semanan Subdistrict, Jakarta. Participants underwent non-contact facial scanning using an rPPG system alongside standard laboratory measurements of HbA1c and blood glucose. Agreement was assessed using Bland–Altman analysis and Cohen’s Kappa. Diagnostic performance was evaluated using sensitivity, specificity, predictive values, and receiver operating characteristic (ROC) curve analysis. rPPG-derived HbA1c showed a significant mean difference compared with laboratory measurements (0.63%; p < 0.001; 95% CI: 0.34–0.93), indicating systematic bias. Categorical agreement was poor (κ = 0.029; p = 0.403). In screening analysis, sensitivity ranged from 65.38% to 97.37%, while specificity ranged from 8.91% to 59.55%, with consistently high negative predictive values (≥82%). ROC analysis demonstrated an AUC of 0.668 (p = 0.008) for diabetes and 0.711 (p < 0.001) for prediabetes, indicating modest to acceptable discriminative ability. rPPG-based HbA1c estimation lacks sufficient agreement for diagnostic use. However, its relatively high sensitivity and scalability suggest that it may warrant further evaluation as a non-invasive screening tool for early detection and population-level risk stratification within mobile health settings.
Keywords
Full Text:
PDFReferences
K. L. Ong, et al, “Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021,” Lancet, vol. 402, no. 10397, pp. 203–234, Jul. 2023. Available: https://doi.org/10.1016/S0140-6736(23)01301-6.
D. J. Magliano and E. J. Boyko, IDF DIABETES ATLAS [Internet], 10th ed. Brussels: International Diabetes Federation, 2021. Available: https://www.ncbi.nlm.nih.gov/books/NBK581934/
E. Ahmad, S. Lim, R. Lamptey, D. R. Webb, and M. J. Davies, “Type 2 diabetes,” Lancet, vol. 400, no. 10365, pp. 1803–1820, Nov. 2022. Available: https://doi.org/10.1016/S0140-6736(22)01655-5.
B. Zhou, A, “Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants,” Lancet, vol. 404, no. 10467, pp. 2077–2093, Nov. 2024. Available: https://doi.org/10.1016/S0140-6736(24)02317-1.
M. J. Hossain, M. Al‐Mamun, and M. R. Islam, “Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused,” Heal. Sci. Reports, vol. 7, no. 3, Mar. 2024. Available: https://doi.org/10.1002/hsr2.2004.
R. S. Hanifa, et al, “Cost-effectiveness of community-based type 2 diabetes prevention and control in Indonesia: a health economics modelling study,” BMJ Public Heal., vol. 3, no. 2, p. e002161, Jul. 2025. Available: https://doi.org/10.1136/bmjph-2024-002161.
T. Siswati, H. S. Kasjono, and Y. Olfah, “‘Posbindu PTM’: The Key of Early Detection and Decreasing Prevalence of Non-Communicable Diseases in Indonesia,” Iran. J. Public Health, Jul. 2022. Available: https://doi.org/10.18502/ijph.v51i7.10105.
K. Ogurtsova, et al, “IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021,” Diabetes Res. Clin. Pract., vol. 183, p. 109118, Jan. 2022. Available: https://doi.org/10.1016/j.diabres.2021.109118.
P.-K. Man, et al, “Blood Pressure Measurement: From Cuff-Based to Contactless Monitoring,” Healthcare, vol. 10, no. 10, p. 2113, Oct. 2022. Available: https://doi.org/10.3390/healthcare10102113.
F. Haugg, M. Elgendi, and C. Menon, “Effectiveness of Remote PPG Construction Methods: A Preliminary Analysis,” Bioengineering, vol. 9, no. 10, p. 485, Sep. 2022. Available: https://doi.org/10.3390/bioengineering9100485.
J. Chu, W.-T. Yang, W.-R. Lu, Y.-T. Chang, T.-H. Hsieh, and F.-L. Yang, “90% Accuracy for Photoplethysmography-Based Non-Invasive Blood Glucose Prediction by Deep Learning with Cohort Arrangement and Quarterly Measured HbA1c,” Sensors, vol. 21, no. 23, p. 7815, Nov. 2021. Available: https://doi.org/10.3390/s21237815.
B. Shi, et al, “Assessing Elevated Blood Glucose Levels Through Blood Glucose Evaluation and Monitoring Using Machine Learning and Wearable Photoplethysmography Sensors: Algorithm Development and Validation,” JMIR AI, vol. 2, p. e48340, Oct. 2023. Available: https://doi.org/10.2196/48340.
S. Zanelli, M. Ammi, M. Hallab, and M. A. El Yacoubi, “Diabetes Detection and Management through Photoplethysmographic and Electrocardiographic Signals Analysis: A Systematic Review,” Sensors, vol. 22, no. 13, p. 4890, Jun. 2022. Available: https://doi.org/10.3390/s22134890.
M. Zeynali, K. Alipour, B. Tarvirdizadeh, and M. Ghamari, “Non-invasive blood glucose monitoring using PPG signals with various deep learning models and implementation using TinyML,” Sci. Rep., vol. 15, no. 1, p. 581, Jan. 2025. Available: https://doi.org/10.1038/s41598-024-84265-8.
Y. K. Qawqzeh, A. S. Bajahzar, M. Jemmali, M. M. Otoom, and A. Thaljaoui, “[Retracted] Classification of Diabetes Using Photoplethysmogram (PPG) Waveform Analysis: Logistic Regression Modeling,” Biomed Res. Int., vol. 2020, no. 1, Jan. 2020. Available: https://doi.org/10.1155/2020/3764653.
D. Qiao, A. H. Ayesha, F. Zulkernine, N. Jaffar, and R. Masroor, “ReViSe: Remote Vital Signs Measurement Using Smartphone Camera,” IEEE Access, vol. 10, pp. 131656–131670, 2022. Available: https://doi.org/10.1109/ACCESS.2022.3229977.
D. Kraft, G. Bieber, and M. Fellmann, “Reliability factor for accurate remote PPG systems,” in Proceedings of the 16th International Conference on PErvasive Technologies Related to Assistive Environments, 2023, pp. 448–456. Available: https://doi.org/10.1145/3594806.3596573.
G. Jain, A. M. Joshi, R. K. Maddila, and S. K. Vipparthi, “A Review of Non-Invasive HbA1c and Blood Glucose Measurement Methods,” in 2021 IEEE International Symposium on Smart Electronic Systems (iSES), 2021, pp. 339–342. Available: https://doi.org/10.1109/iSES52644.2021.00086.
M. A. Almarshad, M. S. Islam, S. Al-Ahmadi, and A. S. BaHammam, “Diagnostic Features and Potential Applications of PPG Signal in Healthcare: A Systematic Review,” Healthcare, vol. 10, no. 3, p. 547, Mar. 2022. Available: https://doi.org/10.3390/healthcare10030547.
M. S. Popoviciu, T. C. Ghitea, C. Pantis, N. O. Pop, and R. D. Brata, “HbA1c-Based Metabolic Stratification: A Retrospective Study of Clinical and Biological Differences Across Normoglycemic, Prediabetic, and Diabetic Subjects,” Diagnostics, vol. 16, no. 4, p. 566, Feb. 2026. Available: https://doi.org/10.3390/diagnostics16040566.
F. Li and H. He, “Assessing the Accuracy of Diagnostic Tests.,” Shanghai Arch. psychiatry, vol. 30, no. 3, pp. 207–212, Jun. 2018. Available: https://doi.org/10.11919/j.issn.1002-0829.218052.
O. Gerke, “Reporting Standards for a Bland–Altman Agreement Analysis: A Review of Methodological Reviews,” Diagnostics, vol. 10, no. 5, p. 334, May 2020. Available: https://doi.org/10.3390/diagnostics10050334.
N. Ö. Doğan, “Bland-Altman analysis: A paradigm to understand correlation and agreement,” Turkish J. Emerg. Med., vol. 18, no. 4, pp. 139–141, Dec. 2018. Available: https://doi.org/10.1016/j.tjem.2018.09.001.
K. V Wood, A. Moore, M. Ahmad, and D. N. Bostanci, “Remote photoplethysmography for cardiorespiratory self-monitoring: A qualitative study of usability, convenience, and patient confidence,” Digit. Heal., vol. 12, Feb. 2026. Available: https://doi.org/10.1177/20552076261435829.
J. W. Chin, et al, “Clinical Validation of rPPG-Enabled Contactless Pulse Rate Monitoring Software in Cardiovascular Disease Patients,” Bioengineering, vol. 13, no. 2, p. 246, Feb. 2026. Available: https://doi.org/10.3390/bioengineering13020246.
L. J. Pu, Y. Shen, L. Lu, R. Y. Zhang, Q. Zhang, and W. F. Shen, “Increased blood glycohemoglobin A1c levels lead to overestimation of arterial oxygen saturation by pulse oximetry in patients with type 2 diabetes,” Cardiovasc. Diabetol., vol. 11, no. 1, p. 110, Dec. 2012. Available: https://doi.org/10.1186/1475-2840-11-110.
N. Nirala, R. Periyasamy, B. K. Singh, and A. Kumar, “Detection of type-2 diabetes using characteristics of toe photoplethysmogram by applying support vector machine,” Biocybern. Biomed. Eng., vol. 39, no. 1, pp. 38–51, Jan. 2019. Available: https://doi.org/10.1016/j.bbe.2018.09.007.
A. Hina and W. Saadeh, “A Noninvasive Glucose Monitoring SoC Based on Single Wavelength Photoplethysmography,” IEEE Trans. Biomed. Circuits Syst., vol. 14, no. 3, pp. 504–515, Jun. 2020. Available: https://doi.org/10.1109/TBCAS.2020.2979514.
H.-C. Wei, M.-X. Xiao, H.-Y. Chen, Y.-Q. Li, H.-T. Wu, and C.-K. Sun, “Instantaneous frequency from Hilbert-Huang transformation of digital volume pulse as indicator of diabetes and arterial stiffness in upper-middle-aged subjects,” Sci. Rep., vol. 8, no. 1, p. 15771, Oct. 2018. Available: https://doi.org/10.1038/s41598-018-34091-6.
T. Shaik, X. Tao, N. Higgins, L. Li, R. Gururajan, X. Zhou, and U. R. Acharya, “Remote patient monitoring using artificial intelligence: Current state, applications, and challenges,” WIREs Data Min. Knowl. Discov., vol. 13, no. 2, Mar. 2023. Available: https://doi.org/10.1002/widm.1485.
G. Casalino, G. Castellano, and G. Zaza, “Evaluating the robustness of a contact-less mHealth solution for personal and remote monitoring of blood oxygen saturation,” J. Ambient Intell. Humaniz. Comput., vol. 14, no. 7, pp. 8871–8880, Jul. 2023. Available: https://doi.org/10.1007/s12652-021-03635-6.
R. Avram, et al, “A digital biomarker of diabetes from smartphone-based vascular signals,” Nat. Med., vol. 26, no. 10, pp. 1576–1582, Oct. 2020. Available: https://doi.org/10.1038/s41591-020-1010-5.
S. W. Kim, S. C. Kim, K. C. Nam, E. S. Kang, J. J. Im, and D. W. Kim, “A new method of screening for diabetic neuropathy using laser Doppler and photoplethysmography,” Med. Biol. Eng. Comput., vol. 46, no. 1, pp. 61–67, Jan. 2008. Available: https://doi.org/10.1007/s11517-007-0257-z.
H.-C. Wei, et al, “Digital Volume Pulse Measured at the Fingertip as an Indicator of Diabetic Peripheral Neuropathy in the Aged and Diabetic,” Entropy, vol. 21, no. 12, p. 1229, Dec. 2019. Available: https://doi.org/10.3390/e21121229.
H.-C. Wei, et al, “Percussion Entropy Analysis of Synchronized ECG and PPG Signals as a Prognostic Indicator for Future Peripheral Neuropathy in Type 2 Diabetic Subjects,” Diagnostics, vol. 10, no. 1, p. 32, Jan. 2020. Available: https://doi.org/10.3390/diagnostics10010032.
K. Liao, S.-H. Wang, L.-T. Tsai, Y.-C. Chen, T.-C. Wang, and G.-C. Wang, “A non-invasive harmonic analysis to assess risk of retinopathy in type 2 diabetes mellitus,” J. Diabetes Complications, vol. 36, no. 10, p. 108306, Oct. 2022. Available: https://doi.org/10.1016/j.jdiacomp.2022.108306.
D. Di Lernia, G. Finotti, M. Tsakiris, G. Riva, and M. Naber, “Remote photoplethysmography (rPPG) in the wild: Remote heart rate imaging via online webcams,” Behav. Res. Methods, vol. 56, no. 7, pp. 6904–6914, Apr. 2024. Available: https://doi.org/10.3758/s13428-024-02398-0.
J. Park, H. S. Seok, S.-S. Kim, and H. Shin, “Photoplethysmogram Analysis and Applications: An Integrative Review,” Front. Physiol., vol. 12, Mar. 2022. Available: https://doi.org/10.3389/fphys.2021.808451.
Y. Ben-Haim and C. C. Dacso, “Interpreting PPV and NPV of Diagnostic Tests with Uncertain Prevalence,” Rambam Maimonides Med. J., vol. 15, no. 3, p. e0013, Jul. 2024. Available: https://doi.org/10.5041/RMMJ.10527.
R. Trevethan, “Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice,” Front. Public Heal., vol. 5, Nov. 2017. Available: https://doi.org/10.1186/s12985-024-02371-5.
K. Manten, et al, “Clinical accuracy of instrument-based SARS-CoV-2 antigen diagnostic tests: a systematic review and meta-analysis,” Virol. J., vol. 21, no. 1, p. 99, Apr. 2024. Available:
S. Y. L. Tan, et al, “Remote Photoplethysmography Technology for Blood Pressure and Hemoglobin Level Assessment in the Preoperative Assessment Setting: Algorithm Development Study,” JMIR Form. Res., vol. 9, pp. e60455–e60455, Jun. 2025. Available: https://doi.org/10.2196/60455.
A. Radley, et al, “Implementation of point-of-care HbA1C instruments into community pharmacies: Initial development of a pathway for robust community testing,” Ann. Clin. Biochem. Int. J. Lab. Med., vol. 61, no. 4, pp. 273–283, Jul. 2024. Available: https://doi.org/10.1177/00045632231219380.
A. Gourlay, C. Sutherland, and A. Radley, “Point-of-care testing of HbA1c levels in community settings for people with established diabetes or people at risk of developing type 2 diabetes: a systematic review and meta-analysis protocol,” BMJ Open, vol. 13, no. 5, p. e072882, May 2023. Available: https://doi.org/10.1136/bmjopen-2023-072882.
M. Koga, S. Inada, K. Yoshino, and A. Miyazaki, “IFCC-HbA1c May Be More Useful than NGSP-HbA1c in the Comparison between HbA1c Values in Variant Hemoglobin with a Mutation on α Chain and β Chain.,” Ann. Clin. Lab. Sci., vol. 49, no. 5, pp. 650–655, Sep. 2019. Available: https://www.annclinlabsci.org/content/49/5/650.full
F. H. Rakotonjafiniarivo, S. M. Rakotomalala, T. Antsonantenaina, and M. K. Ranaivosoa, “Comparative Performance of a Routine Immunoturbidimetric Glycated Hemoglobin Assay and High-Pressure Liquid Chromatography Method,” Cureus, Jan. 2026. Available: https://doi.org/10.7759/cureus.101019.
L. Deng, L. Jia, X.-L. Wu, and M. Cheng, “Association Between Body Mass Index and Glycemic Control in Type 2 Diabetes Mellitus: A Cross-Sectional Study,” Diabetes, Metab. Syndr. Obes., vol. Volume 18, pp. 555–563, Feb. 2025. Available: https://doi.org/10.2147/DMSO.S508365.
W. Lin, “The Association between Body Mass Index and Glycohemoglobin (HbA1c) in the US Population’s Diabetes Status,” Int. J. Environ. Res. Public Health, vol. 21, no. 5, p. 517, Apr. 2024. Available: https://doi.org/10.3390/ijerph21050517.
M. M. Mohamad Salleh, M. R. Isa, M. Md. Yasin, N. Mohd Azahar, and M. R. Mohd Lutpi, “Association between body mass index and diabetes mellitus control classification among patients with type 2 diabetes mellitus: Evidence from the National Diabetes Registry of Muar District Health Office, Malaysia, from January 2021 to July 2023,” Malaysian Fam. Physician, vol. 20, p. 23, Apr. 2025. Available: https://doi.org/10.51866/oa.794.
M. Norberg, J. W. Eriksson, B. Lindahl, C. Andersson, O. Rolandsson, H. Stenlund, and L. Weinehall, “A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed,” J. Intern. Med., vol. 260, no. 3, pp. 263–271, Sep. 2006. Available: https://doi.org/10.1111/j.1365-2796.2006.01689.x.
S. Hossain, A. I. Chowdhury, M. N. Sarwer, F. Akter, and N. A. Mukta, “Association Between Blood Glucose and Body Mass Index With Dietary Diversity and Physical Activity: A Cross‐Sectional Study on Marma Tribes of Bandarban in Bangladesh,” Heal. Sci. Reports, vol. 8, no. 7, Jul. 2025. Available: https://doi.org/10.1002/hsr2.71113.
DOI: https://doi.org/10.47738/jads.v7i4.1433
Refbacks
- There are currently no refbacks.
Journal of Applied Data Sciences
| ISSN | : | 2723-6471 (Online) |
| Publisher | : | Bright Publisher |
| Website | : | http://bright-journal.org/JADS |
| : | taqwa@amikompurwokerto.ac.id (principal contact) | |
| support@bright-journal.org (technical issues) |
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0